RAD51-IN-2, identified by its CAS number 2301085-04-9, is a small molecule inhibitor that targets the RAD51 protein, which plays a crucial role in DNA repair processes, particularly in homologous recombination. This compound is of interest in cancer research due to its potential to enhance the efficacy of certain chemotherapeutic agents by disrupting the DNA repair mechanisms in cancer cells. RAD51-IN-2 is characterized by its ability to selectively inhibit RAD51's function, thereby sensitizing tumor cells to DNA-damaging treatments. The compound's structure typically includes specific functional groups that facilitate its interaction with the RAD51 protein, although detailed structural information is proprietary. In preclinical studies, RAD51-IN-2 has shown promise in various cancer models, indicating its potential as a therapeutic agent in combination therapies. As with many investigational compounds, further studies are necessary to fully understand its pharmacokinetics, toxicity, and overall therapeutic potential in clinical settings.

RAD51-IN-2

2301085-04-9: RAD51-IN-2, identified by its CAS number 2301085-04-9, is a small molecule inhibitor that targets the RAD51 protein, which plays a crucial role in DNA repair processes, particularly in homologous recombination. This compound is of interest in cancer research due to its potential to enhance the efficacy of certain chemotherapeutic agents by disrupting the DNA repair mechanisms in cancer cells. RAD51-IN-2 is characterized by its ability to selectively inhibit RAD51's function, thereby sensitizing tumor cells to DNA-damaging treatments. The compound's structure typically includes specific functional groups that facilitate its interaction with the RAD51 protein, although detailed structural information is proprietary. In preclinical studies, RAD51-IN-2 has shown promise in various cancer models, indicating its potential as a therapeutic agent in combination therapies. As with many investigational compounds, further studies are necessary to fully understand its pharmacokinetics, toxicity, and overall therapeutic potential in clinical settings.

Emzadirib

<p>Please enquire for more information about RAD51-IN-2 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Emzadirib (RAD51-IN-2) is a potent RAD51 inhibitor with potential anticancer activity for the study of DNA damage repair.</p>

CAS 2301085-04-9

RAD51-IN-2

Emzadirib

Ref: 54-BUP21820

RAD51-IN-2

Ref: 3D-BSD08504

Emzadirib

Ref: TM-T12682